Annonaceous acetogenins reverses drug resistance of human hepatocellular carcinoma BEL-7402/5-FU and HepG2/ADM cell lines

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 9, 2015, Pages 11934-11944

  Qian, Jun Qiang ^a   Sun, Pei ^a   Pan, Zhan Yu ^a   Fang, Zhi Zhong ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Annonaceous acetogenins; Drug resistance; Hepatocellular carcinoma

Indexed keywords

ACETOGENIN; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; CELL CYCLE PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECTS; DRUG RESISTANCE; HEP-G2 CELL LINE; HUMAN; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ACETOGENINS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 85013290709     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Miamen AG, Dong H, Roberts LR. Immuno-therapeutic approaches to hepatocellular carcinoma treatment. Liver Cancer 2012; 3-4: 226-237.
2. McGlynn KA, London WT. The Global Epide-miology of Hepatocellular Carcinoma: Present and Future. Clin Liver Dis 2011; 2: 223-243.
3. Liu CL, Lim YP, Hu ML. Fucoxanthin attenuates rifampin-induced cytochrome P450 3A4 (CYP-3A4) and multiple drug resistance 1 (MDR1) gene expression through pregnane X receptor (PXR)-mediated pathways in human hepatoma HepG2 and colon adenocarcinoma LS174T cells. Mar Drugs 2012; 1: 242-57.
4. Guha M, Altieri DC. Survivin as a global target of intrinsic tumor suppression networks. Cell Cycle 2009; 17: 2708-2710.
5. Zhu Y, Liu XJ, Yang P, Zhao M, Lv LX, Zhang GD, Wang Q, Zhang L. Alkylglyceronephosphate synthase (AGPS) alters lipid signaling pathways and supports chemotherapy resistance of glioma and hepatic carcinoma cell lines. Asian Pac J Cancer Prev 2014; 7: 3219-26.
6. Nabekura T. Overcoming multidrug resistance in human cancer cells by natural compounds. Toxins 2010; 6: 1207-1224.
7. Huang GR, Jiang S, Wu YL, Jin Y, Yao ZJ, Wu JR. Induction of cell death of gastric cancer cells by a modified compound of the annonaceous acetogenin family. Chembiochem 2003; 11: 1216-1221.
8. Landolt JL, Ahammadsahib KI, Hollingworth RM. Determination of structure-activity relationships of Annonaceous acetogenins by inhibition of oxygen uptake in rat liver mitochondria. Chem Biol Interact 1995; 1: 1-13.
9. Wijnholds J. Drug resistance caused by multidrug resistance-associated proteins. Novartis Found Symp 2012; 243: 69-79.
10. Seo SB, Hur JG, Kim MJ. TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3beta pathway and activation of caspases. Mol Cancer 2010; 9: 199.
11. Geng M, Wang L, Chen X, Cao R, Li P. The association between chemosensitivity and Pgp, GST-p and Topo II expression in gastric cancer. Diagn Pathol 2013; 8: 198.
12. Zhou YT, Li K, Tian H. Effects of vinorelbine on cisplatin resistance reversal in human lung cancer A549/DDP cells. Asian Pac J Cancer Prev 2013; 8: 4635-4639.
13. Yamamoto Y, Konishi H, Ichikawa D, Arita T, Shoda K, Komatsu S, Shiozaki A, Ikoma H, Fujiwara H, Okamoto K, Ochiai T, Inoue J, Inazawa J, Otsuji E. Significance of GSTP1 for predicting the prognosis and chemotherapeutic efficacy in esophageal squamous cell carcinoma. Oncol Rep 2013; 4: 1687-1694.
14. Roos WP, Kaina B. DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett 2013; 3322: 237-248.
15. Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 2014; 1: 49-63.
16. Cheng L, Luo S, Jin C, Ma H, Zhou H, Jia L. FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K/Akt signaling pathway. Cell Death Dis 2013; 4: e923.
17. Gao XD, Qu JH, Chang XJ, Lu YY, Bai WL, Wang H, Xu ZX, An LJ, Wang CP, Zeng Z, Yang YP. Hypomethylation of long interspersed nuclear element-1 promoter is associated with poor outcomes for curative resected hepatocellular carcinoma. Liver Int 2014; 1: 136-146.
18. Wu Q, Yang Z, Nie Y, Shi Y, Fan D. Multi-drug resistance in cancer chemotherapeutics: me-chanisms and lab approaches. Cancer Lett 2014; 2: 159-166.
19. Kawaguchi T, Yamagishi S, Sata M. Branched-chain amino acids and pigment epithelium-derived factor: novel therapeutic agents for hepatitis c virus-associated insulin resistance. Curr Med Chem 2009; 36: 4843-4857.
20. Bakos E, Homolya L. Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1). Pflugers Arch 2007; 5: 621-641.
21. Bentires-Alj M, Barbu V, Fillet M, Chariot A, Relic B, Jacobs N, Gielen J, Merville MP, Bours V. NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene 2003; 1: 90-97.
22. Deng L, Lin-Lee YC, Claret FX, Kuo MT. 2-acetylaminofluorene up-regulates rat mdr1b expression through generating reactive oxygen species that activate NF-kappa B pathway. J Biol Chem 2001; 1: 413-420.
23. Hochhauser D, Schnieders B, Ercikan-Abali E, Gorlick R, Muise-Helmericks R, Li WW, Fan J, Banerjee D, Bertino JR. Effect of cyclin D1 overexpression on drug sesitivity in a human fibrosarcoma cell line. J Natl Cancer Inst 1996; 18: 1269-1275.
24. Qi F, Inagaki Y, Gao B, Cui X, Xu H, Kokudo N, Li A, Tang W. Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas-and mitochondria-mediated pathways. Cancer Sci 2011; 102: 951-958.
25. Wang CD, Yuan CF, Bu YQ, Wu XM, Wan JY, Zhang L, Hu N, Liu XJ, Zu Y, Liu GL, Song FZ. Fangchinoline inhibits cell proliferation via Akt/GSK-3beta/cyclin D1 signaling and induces apoptosis in MDA-MB-231 breast cancer cells. Asian Pac J Cancer Prev 2014; 2: 769-773.
26. Sommermann TG, O'Neill K, Plas DR, Cahir-McFarland E. IKKβ and NF-κB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GL-UT1. Cancer Res 2011; 23: 7291-7300.
27. Courtney KD, Corcoran RB, Engelman JA. The PI3K pathway as drug target in human cancer. J Clin Oncol 2010; 6: 1075-1083.
28. Wang C, Lisanti MP, Liao DJ. Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology. Cell Cycle 2011; 1: 57-67.